$派格生物医药-B(_老虎社区_美港股上老虎

$派格生物医药-B(02565)$ 派格产品CR059的突破性进展不仅巩固了公司在GLP-1领域的研发实力，更将其产品潜力从百亿级的糖尿病市场，延伸至用户依从性要求更高、市场空间更广阔的减重等领域

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":541461719885040,"tweetId":"541461719885040","gmtCreate":1773218302992,"gmtModify":1773218305329,"author":{"id":4203909980173582,"idStr":"4203909980173582","authorId":4203909980173582,"authorIdStr":"4203909980173582","name":"Y2301156","avatar":"https://static.tigerbbs.com/cba88a66df5e28ed78bd3f5925c72e69","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 派格产品CR059的突破性进展不仅巩固了公司在GLP-1领域的研发实力，更将其产品潜力从百亿级的糖尿病市场，延伸至用户依从性要求更高、市场空间更广阔的减重等领域</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 派格产品CR059的突破性进展不仅巩固了公司在GLP-1领域的研发实力，更将其产品潜力从百亿级的糖尿病市场，延伸至用户依从性要求更高、市场空间更广阔的减重等领域</p></body></html>","text":"$派格生物医药-B(02565)$ 派格产品CR059的突破性进展不仅巩固了公司在GLP-1领域的研发实力，更将其产品潜力从百亿级的糖尿病市场，延伸至用户依从性要求更高、市场空间更广阔的减重等领域","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/541461719885040","repostId":0,"isVote":1,"tweetType":1,"viewCount":236,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02565"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":170,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}